Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
Novavax stock zipped higher and then plunged Thursday after the FDA set a potential approval date for its Covid vaccine in April.